James Randall Owen

Title: Innovations by James Randall Owen in Alzheimer's Disease Treatment

Introduction

James Randall Owen is an accomplished inventor based in Princeton, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease psychosis. His innovative approach focuses on the use of pimavanserin, a compound that has shown promise in alleviating symptoms associated with dementia.

Latest Patents

James Randall Owen holds a patent for "Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis." This patent outlines methods for treating Alzheimer's disease psychosis, including the administration of pimavanserin or its pharmaceutically acceptable salts. The patent also details methods for reducing delusions, hallucinations, and agitated or aggressive behavior in individuals with dementia through the use of this compound. His work aims to improve the quality of life for patients suffering from these debilitating symptoms.

Career Highlights

Owen is currently associated with Acadia Pharmaceuticals Inc., where he continues to develop and refine treatments for neurological disorders. His dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry, particularly in the realm of mental health.

Collaborations

James Randall Owen has collaborated with notable colleagues, including Bruce Duane Coate and Mark Donald Knowles. These partnerships have fostered a collaborative environment that enhances the development of effective treatments for Alzheimer's disease and related conditions.

Conclusion

James Randall Owen's contributions to the treatment of Alzheimer's disease psychosis through his innovative patent demonstrate his commitment to improving patient care. His work at Acadia Pharmaceuticals Inc. and collaborations with esteemed colleagues further highlight his impact in the field of medicine.